Zymeworks Inc - Company & Market Research Reports

Zymeworks is a computational biotechnology company. The company's focus is in the research and development of industrial enzymes and protein therapeutics for chemical, and pharmaceutical industries. Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. The products are based upon the company's molecular modeling software for optimizing protein structure. The company is based in Vancouver, British Columbia.

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Protein Expression Systems Market: Current Landscape and Future Opportunities - Product Thumbnail Image

Protein Expression Systems Market: Current Landscape and Future Opportunities

  • Report
  • 249 Pages
From
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026 - Product Thumbnail Image

Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026

  • Report
  • 327 Pages
From
Cell Line Development Services Market, 2017-2027 - Product Thumbnail Image

Cell Line Development Services Market, 2017-2027

  • Report
  • 278 Pages
From
Contract Biomanufacturing Services Global Market - Forecast to 2025 - Product Thumbnail Image

Contract Biomanufacturing Services Global Market - Forecast to 2025

  • Report
  • 206 Pages
From
Zymeworks Inc. - Product Pipeline Review - 2015 - Product Thumbnail Image

Zymeworks Inc. - Product Pipeline Review - 2015

  • Company Profile
  • 35 Pages
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2412 Pages
From
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals - Product Thumbnail Image

T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals

  • Report
  • 230 Pages
From
Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022 - Product Thumbnail Image

Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022

  • Report
  • 80 Pages
From
Metastatic Breast Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • Drug Pipelines
  • 1096 Pages
From
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 1674 Pages
From
Breast Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2016

  • Drug Pipelines
  • 3011 Pages
From
Metastatic Breast Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H1 2016

  • Drug Pipelines
  • 1079 Pages
From
Metastatic Breast Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H2 2015

  • Drug Pipelines
  • 966 Pages
From
Anti-VEGF Antibodies: Global Technology Assessment, Market Analysis and Future Growth Trends - Product Thumbnail Image

Anti-VEGF Antibodies: Global Technology Assessment, Market Analysis and Future Growth Trends

  • Report
  • 140 Pages
From
Metastatic Breast Cancer - Pipeline Review, H1 2015 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H1 2015

  • Drug Pipelines
  • 866 Pages
From
Zymeworks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

Zymeworks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 145 Pages
From
Zymeworks Inc - Product Thumbnail Image

Zymeworks Inc

  • Company Profile
  • 62 Pages
Q2 2017 Earnings Call - Zymeworks, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - Zymeworks, Inc., - Earnings Transcript

  • Earnings Transcript
Q1 2017 Earnings Call - Zymeworks, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2017 Earnings Call - Zymeworks, Inc., - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll